Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Blood Monocytes as a Predictive Marker of Cystic Fibrosis-related Bone Disease

NCT04877223 is registered in ClinicalTrials.gov with Université de Reims Champagne-Ardenne as lead sponsor.

NCT NCT04877223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04877223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Blood Monocytes as a Predictive Marker of Cystic Fibrosis-related Bone Disease
Lead sponsor
Université de Reims Champagne-Ardenne
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
November 1, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis